Speech-Language Pathologists in Dardenne Prairie, MO Accepting Medicare

7 Speech-Language Pathologists found. Showing 1 - 7

Elizabeth Ann Carter, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7421 S. Outer 364, Suite B, Dardenne Prairie, MO 63368 Phone: 636-561-2060    Fax: 636-561-4380

Carolyn Wiegers, M.S. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2025 Hanley Rd, Dardenne Prairie, MO 63368 Phone: 636-926-2700    Fax: 636-447-4919

Mrs. Heather Christine Williams, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2452 Shetland Dr, Dardenne Prairie, MO 63368 Phone: 636-346-6322

Mrs. Lisa Ann Agee, MA, L/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7370 Weldon Springs Rd, Dardenne Prairie, MO 63368 Phone: 636-851-5372

Caitlyn Schepker, M.S. CFY-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1030 Barathaven Dr, Dardenne Prairie, MO 63368 Phone: 216-772-1030    Fax: 586-261-6028

Mrs. Kelly Lynn Voisey, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2019 Avalon Mist Cir, Dardenne Prairie, MO 63368 Phone: 636-294-4566    Fax: 636-294-4566

Jennifer A. Graham Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7370 Weldon Spring Rd, Dardenne Prairie, MO 63368 Phone: 636-851-5388

News Archive

Researchers identify immune system marker that drives therapy-resistant prostate cancer

You are a patient who has just been treated for a serious illness but neither you nor your doctor knows how likely it is that you - in comparison with other patients - will actually be helped by the treatment. This is often the situation with prostate cancer, one of the deadliest and most highly prevalent cancers. While hormone therapy can help, patient responses vary widely, and it's still unclear why some types of prostate cancer seem to be resistant to the therapy.

New natural dietary components inhibit breast cancer cells

Researchers at Indiana University and Methodist Research Institute have published the dramatic effects of a natural formula against breast cancer. The impressive results are found in the most recent publication of Integrative Cancer Therapies. Lead investigator Dr. Daniel Sliva says, The formula we studied inhibits growth of highly metastatic human breast cancer cells, and suppresses metastatic potential of these cells.

Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients

A subanalysis of the phase III ALEX study has shown that alectinib 600 mg twice daily is more effective than standard of care crizotinib in Asian patients with anaplastic lymphoma kinase (ALK) positive non-small-cell lung cancer (NSCLC), researchers report at the ESMO Asia 2017 Congress.

Accentus Medical signs licence agreement for Agluna anti-infective technology with Zimmer

Accentus Medical, a leading UK medical technology company that supplies advanced coatings and surface treatments to the medical device industry, announced today that it has signed a Licence and Services Agreement with Zimmer Holdings, Inc., a global market leader in musculoskeletal care. This agreement will enable the use of Accentus Medical's Agluna® anti-infective technology on a potentially broad range of Zimmer products.

Read more Medical News

› Verified 2 days ago